Please use this identifier to cite or link to this item: 10.2478/prolas-2019-0016
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTretjakovs, Peteris-
dc.contributor.authorHofmanis, Juris-
dc.contributor.authorHofmane, Dace-
dc.contributor.authorKrieviņa, Gita-
dc.contributor.authorBlumfelds, Leons-
dc.contributor.authorMackevičs, Vitolds-
dc.contributor.authorLejnieks, Aivars-
dc.contributor.authorBahs, Guntis-
dc.date.accessioned2021-04-28T09:30:01Z-
dc.date.available2021-04-28T09:30:01Z-
dc.date.issued2019-05-01-
dc.identifier.citationTretjakovs , P , Hofmanis , J , Hofmane , D , Krieviņa , G , Blumfelds , L , Mackevičs , V , Lejnieks , A & Bahs , G 2019 , ' Prognostic utility of novel biomarkers in aortic valve stenosis ' , Proceedings of the Latvian Academy of Sciences, Section B: Natural, Exact, and Applied Sciences , vol. 73 , no. 2 , pp. 100-106 . https://doi.org/10.2478/prolas-2019-0016-
dc.identifier.issn1407-009X-
dc.identifier.urihttps://dspace.rsu.lv/jspui/handle/123456789/3964-
dc.descriptionFunding Information: This study was supported in part by grant No. 2014.10-4/VPP-1.1.2 of the framework of the Latvian National Programme. Publisher Copyright: © 2019 Peteris Tretjakovs et al., published by Sciendo 2019.-
dc.description.abstractThe aim of the present study was to evaluate plasma levels of chemerin, myeloperoxidase (MPO), fibroblast growth factor-21 (FGF-21), thioredoxin reductase-1 (TrxR1), and matrix metallopeptidase-9 (MMP-9) in acquired aortic valve (AoV) stenosis patients to determine correlations between the studied cellular factors, and also clarify the predictive values of these factors as biomarkers in AoV stenosis. AoV stenosis patients were classified into three groups: 17 patients with mild AoV stenosis; 19 with moderate and 15 with severe AoV stenosis. Twenty-four subjects without AoV stenosis were selected as a control group. Our findings suggest that AoV stenosis might be associated with increased chemerin, TrxR1, MPO, and FGF-21 levels in plasma. Moreover, these factors and also MMP-9 already reached statistically significantly elevated levels in the early stages of AoV stenosis, but MPO levels were more pronounced in patients with moderate and severe AoV stenosis. Chemerin was correlated with all of the studied cytokines; TrxR1 and MMP-9 were correlated with several other cellular factors. Our findings (by ROC analysis) suggest that MPO and chemerin might serve as specific and sensitive biomarkers for AoV stenosis without grading the severity, but, in relation to mild AoV stenosis, TrxR1, FGF-21, and MMP-9 also reached good or moderate levels as biomarkers. The cellular factors might serve as novel diagnostic and prognostic biomarkers in AoV stenosis patients, while chemerin and MPO may be more powerful.en
dc.format.extent7-
dc.format.extent360176-
dc.language.isoeng-
dc.relation.ispartofProceedings of the Latvian Academy of Sciences, Section B: Natural, Exact, and Applied Sciences-
dc.rightsinfo:eu-repo/semantics/openAccess-
dc.subjectaortic valve stenosis-
dc.subjectchemerin-
dc.subjectfibroblast growth factor-21-
dc.subjectmatrix metalloproteinase-9-
dc.subjectmyeloperoxidase-
dc.subjectthioredoxin reductase-1-
dc.subject3.2 Clinical medicine-
dc.subject1.1. Scientific article indexed in Web of Science and/or Scopus database-
dc.subjectGeneral-
dc.titlePrognostic utility of novel biomarkers in aortic valve stenosisen
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article-
dc.identifier.doi10.2478/prolas-2019-0016-
dc.contributor.institutionFaculty of Medicine-
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85065655590&partnerID=8YFLogxK-
dc.description.statusPeer reviewed-
Appears in Collections:Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure

Files in This Item:
File SizeFormat 
PROGNOSTIC_UTILITY_OF_NOVEL_BIOMARKERS.pdf351.73 kBAdobe PDFView/Openopen_acces_unlocked


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.